Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Gastric cancer represents one of the most frequent and lethal tumors worldwide today, finding itself in the fifth place in incidence and the third in mortality. Surgery remains the only curative treatment for localized tumors, but only 20% of patients are suitable for surgery due to the lack of specific symptoms and the late diagnosis, especially in Western countries. Additionally, even in patients who receive curative treatment, rates of locoregional relapse and distant metastasis remain high. Palliative chemotherapy is the principal treatment in cases of metastatic disease even if the prognosis of patients receiving chemotherapy is still poor. Therefore, a multidisciplinary evaluation is important in order to improve the efficacy of active treatments. In this context, there is an unmet need for a better understanding of genetic alterations and prognostic and predictive factors in order to choose the best tailored therapy for each patient. The aim of this Special Issue is to focus on the results and problems of multimodality treatment in metastatic gastric cancer, the search for prognostic and predictive factors, and the evaluation of novel strategies for individualized treatment. We are inviting relevant original research, systematic reviews, meta-analyses, and short communications covering the above-mentioned topics.

advanced gastric cancer --- precision medicine --- new drug development --- gastro-oesophageal cancer --- mutational concordance --- exome sequencing --- formalin fixed paraffin embedded --- biomarkers --- gastric cancer --- metastatic --- body composition --- sarcopenia --- visceral fat area --- subcutaneous fat area --- outcome --- toxicity --- liver metastasis --- conversion surgery --- hepatectomy --- stage iv gastric cancer --- immune checkpoint inhibitors --- Epstein Barr Virus --- tumor mutational burden --- microsatellite instability --- predictive biomarkers --- CAR T cell therapy --- vaccines --- nutritional status --- metastatic gastric cancer --- target therapy --- bone flare --- stage IV --- treatment --- RANK-L --- liquid biopsy --- circulating tumor cell --- cfDNA --- ctDNA --- epithelial–mesenchymal transition --- resistance to treatment --- HER2-inhibition --- VEGFR-inhibition --- immunotherapy --- response monitoring --- n/a --- epithelial-mesenchymal transition

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor.

Medicine --- Clinical & internal medicine --- dementia --- behavioral and psychological symptoms of dementia --- systematic review --- meta-analysis --- animal-assisted intervention --- pet-robot intervention --- G protein-coupled receptors --- GPR120 --- FFAR4 --- schizophrenia --- polyunsaturated fatty acids --- long-chain fatty acids --- omega-3 --- nutritional psychiatry --- Alzheimer’s disease --- psychiatric disease --- depression --- anxiety --- Down’s syndrome --- inositol --- nutraceutical --- insulin signaling --- antioxidant --- aging --- psilocybin --- clinical trials --- oxidative stress --- redox --- multiple sclerosis --- biomarker --- neurodegenerative disease --- personalized medicine --- major depressive disorder --- longitudinal study --- LC-MS/MS --- plasma protein biomarker --- drug response monitoring --- multiple reaction monitoring --- diabetes mellitus --- type 2 --- dyslipidemias --- hypertension --- post-stroke depression --- disability level --- mortality --- late-life depression --- neuroimaging --- resting-state functional magnetic resonance imaging --- default mode network --- executive control network --- salience network --- healthy life expectancy (HALE) --- morbidity/mortality paradox --- cognition --- systolic blood pressure --- cerebral blood flow --- arterial properties --- angiogenesis --- gender medicine --- neurodegenerative disorders --- kisspeptin --- locomotion --- Kiss1 receptor --- HPA axis --- HPG axis --- nucleus accumbens --- stroke --- lipid --- diabetes

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor.

Medicine --- Clinical & internal medicine --- dementia --- behavioral and psychological symptoms of dementia --- systematic review --- meta-analysis --- animal-assisted intervention --- pet-robot intervention --- G protein-coupled receptors --- GPR120 --- FFAR4 --- schizophrenia --- polyunsaturated fatty acids --- long-chain fatty acids --- omega-3 --- nutritional psychiatry --- Alzheimer’s disease --- psychiatric disease --- depression --- anxiety --- Down’s syndrome --- inositol --- nutraceutical --- insulin signaling --- antioxidant --- aging --- psilocybin --- clinical trials --- oxidative stress --- redox --- multiple sclerosis --- biomarker --- neurodegenerative disease --- personalized medicine --- major depressive disorder --- longitudinal study --- LC-MS/MS --- plasma protein biomarker --- drug response monitoring --- multiple reaction monitoring --- diabetes mellitus --- type 2 --- dyslipidemias --- hypertension --- post-stroke depression --- disability level --- mortality --- late-life depression --- neuroimaging --- resting-state functional magnetic resonance imaging --- default mode network --- executive control network --- salience network --- healthy life expectancy (HALE) --- morbidity/mortality paradox --- cognition --- systolic blood pressure --- cerebral blood flow --- arterial properties --- angiogenesis --- gender medicine --- neurodegenerative disorders --- kisspeptin --- locomotion --- Kiss1 receptor --- HPA axis --- HPG axis --- nucleus accumbens --- stroke --- lipid --- diabetes --- dementia --- behavioral and psychological symptoms of dementia --- systematic review --- meta-analysis --- animal-assisted intervention --- pet-robot intervention --- G protein-coupled receptors --- GPR120 --- FFAR4 --- schizophrenia --- polyunsaturated fatty acids --- long-chain fatty acids --- omega-3 --- nutritional psychiatry --- Alzheimer’s disease --- psychiatric disease --- depression --- anxiety --- Down’s syndrome --- inositol --- nutraceutical --- insulin signaling --- antioxidant --- aging --- psilocybin --- clinical trials --- oxidative stress --- redox --- multiple sclerosis --- biomarker --- neurodegenerative disease --- personalized medicine --- major depressive disorder --- longitudinal study --- LC-MS/MS --- plasma protein biomarker --- drug response monitoring --- multiple reaction monitoring --- diabetes mellitus --- type 2 --- dyslipidemias --- hypertension --- post-stroke depression --- disability level --- mortality --- late-life depression --- neuroimaging --- resting-state functional magnetic resonance imaging --- default mode network --- executive control network --- salience network --- healthy life expectancy (HALE) --- morbidity/mortality paradox --- cognition --- systolic blood pressure --- cerebral blood flow --- arterial properties --- angiogenesis --- gender medicine --- neurodegenerative disorders --- kisspeptin --- locomotion --- Kiss1 receptor --- HPA axis --- HPG axis --- nucleus accumbens --- stroke --- lipid --- diabetes